PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Scilex Holding Company

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Scilex Holding Company's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Cushion Ratio: Debt, after subtracting cash, is 6.5 times its market value (net debt). Lower than almost all Healthcare companies in United States.
  • Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $219 per $100 of sales comes from others' credit, against $37 tied up three years earlier. Less money tied up than 98% of Healthcare companies in United States.

Where $100 of sales goes

$1,000Operating costs$38Interest$1,186Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

1.5×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.5 times.

Higher than 71% of Healthcare companies in United States.

Cash Locked Ratio

−$219

Money owed to suppliers is larger than money owed by customers plus stock: $219 per $100 of sales comes from others' credit, against $37 tied up three years earlier.

Less money tied up than 98% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 20%

Sales fell 20% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-20% / +322%

In 3 years sales changed by -20% while total assets changed by +322%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

0.0×

Debt due within a year is covered 0.0 times by its yearly operating cash.

Higher than 69% of Healthcare companies in United States.

Cash Cushion Ratio

6.5× debt

Debt, after subtracting cash, is 6.5 times its market value (net debt).

Lower than almost all Healthcare companies in United States.

Tangible Assets Ratio

62%

Of every $100 the company owns, $62 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 67% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+74%

Share count rose 74% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 63% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

Scilex Holding Company made a loss over the last year. Scilex Holding Company owes $2.22 for every $1 it owns. Scilex Holding Company made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Scilex Holding Company made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-0.06

Scilex Holding Company's book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$17 M

The total market value of all of Scilex Holding Company's shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

Negative

Scilex Holding Company's net worth is negative ($308 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Owes vs Owns

2.22×

Scilex Holding Company owes $2.22 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.

Dividend yield

None

Scilex Holding Company does not currently pay a dividend.

Revenue growth

-47%

Revenue fell 47% in the year to Dec 2025, and shrank 7% a year on average over 3 years.

Profit growth

Loss

Scilex Holding Company made a loss in each of the last two years.

Profit margin

-1185.8%

Scilex Holding Company lost $1186 for every $100 of revenue.

Interest cover

Not covered

Scilex Holding Company's operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Scilex Holding Company had $113 M more debt than cash (net debt) at Dec 2025.

Questions

How much does Scilex Holding Company owe compared with what it owns?

Scilex Holding Company owes $2.22 for every $1 it owns, so it owes more than it owns, higher than 97% of Healthcare companies in United States.

Does Scilex Holding Company pay a dividend?

No. Scilex Holding Company does not currently pay a dividend.

Is Scilex Holding Company's revenue growing?

Revenue fell 47% in the year to Dec 2025, and shrank 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.